New Proposals Trial - TROG Cancer Research

TROG Cancer Research

New trial proposal applications are accepted for consideration at any time throughout the year.

There are four types of proposals accepted by TROG Cancer Research from members:

Category A

An investigator-initiated proposal for a trial or registry, submitted by a full TROG Cancer Research member, in which TROG Cancer Research would fulfil the role of lead group and/or sponsor.

Category B

An existing trial, registry or new concept submitted by a full TROG Cancer Research member on behalf of an international trials organisation and where TROG Cancer Research would fulfil the role of the Australia-New Zealand lead group and/or sponsor. The trial/registry would be carried out under the joint auspices of TROG Cancer Research and the group concerned.

Category C

Any trial or project initiated and sponsored by another trials organisation and is for collaboration with TROG Cancer Research.

Category D

An investigator-initiated project that involves data capture, data mining or secondary analysis.

Submission process

Step 1

Complete the online new proposal application.

Step 2

Ensure that any supporting documentation has been uploaded, if applicable.

Step 3

Submit the form by clicking 'Submit' on the last page of the application.

Step 1

Step 2

Complete the TROG new proposal form

Step 3

Please note:

TROG Cancer Research will accept trial concepts, as well as clinical trial proposals for development.
Submitted proposals will be forwarded to the TROG Cancer Research Operations Executive Committee for initial review.
A member of the TROG Cancer Research development team will be in contact after the initial review.
Submissions will progress along the TROG new proposal pathway as outlined in the flowchart below.
TROG Cancer Research development team and working parties can assist in the development of your proposal.

If you have any questions regarding an application or the TROG New Proposal Pathway please contact the TROG team at tsc@trog.com.au

The clinical trial process

There are several stages in the clinical trial process; before, during and after recruitment.

New proposal

A new trial concept, protocol synopsis or full protocol is submitted to the TROG Cancer Research Scientific Committee (TSC) for consideration of presentation and subsequent voting by the TROG Cancer Research Membership at the TROG Cancer Research Annual Scientific Meeting (ASM). Commencement: New Proposal application form received at TROG Cancer Research's Central Operation's Office (TCOO) Conclusion: New Proposal approved for development.

Approved for development

This phase commences when a new proposal has received the endorsement of TROG Cancer Research Membership at the TROG Cancer Research ASM and is approved for development by the TSC. Commencement: New Proposal approved for development. Conclusion: Trial approved for site activation to commence.

Approved for activation

This phase commences when a trial in development has met the ten TROG Cancer Research trial development milestones to the satisfaction of the TSC and given permission to commence site activation processes. A TROG Cancer Research number will be allocated at the commencement of this phase. Commencement: Trial approved for site activation to commence. Conclusion: Activation of first trial site.

Open to accrual

A trial is considered as open (to accrual) when the first trial site has submitted all required regulatory and ethical documentation and has been approved for activation by the Trial Coordinating Centre. Commencement: Activation of first trial site. Conclusion: Accrual of last patient.

Closed to accrual

A trial is considered closed to accrual after the last patient has been recruited. During the closed phase, patients will complete follow up, the main analyses will occur, and processes implemented to complete the trial. Commencement: Accrual of last patient. Conclusion: Official notification from the TROG Cancer Research Scientific Committee indicating that trial is considered completed.

Completed

A trial is completed when the final follow-up has occurred, the trial database has been locked, all analyses have been performed and published, trial sites have been closed, and records archived.

In addition to the above, TROG Cancer Research also provides other Fee-For-Services, such as Radiotherapy Quality Assurance, Trial Management etc. Please contact TROG Cancer Research CEO, Susan Goode for further details.

New Proposals